Compare ALUB & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALUB | PRE |
|---|---|---|
| Founded | N/A | 2014 |
| Country | | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.8M | 369.7M |
| IPO Year | 2026 | N/A |
| Metric | ALUB | PRE |
|---|---|---|
| Price | $10.03 | $17.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 90.6K | ★ 310.6K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $110.85 |
| Revenue Next Year | N/A | $64.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $3.09 |
| 52 Week High | $10.10 | $22.86 |
| Indicator | ALUB | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 47.04 |
| Support Level | $9.98 | $17.00 |
| Resistance Level | $10.10 | $18.48 |
| Average True Range (ATR) | 0.03 | 1.95 |
| MACD | -0.01 | -0.56 |
| Stochastic Oscillator | 46.15 | 35.99 |
Alussa Energy Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.